11.39
11.39 (0.17%)
As of Mar 06, 2024
Altimmune, Inc. [ALT]
Source:
Company Overview
Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for non-alcoholic steatohepatitis (NASH) (ALT-801) and chronic hepatitis B (HepTcell).
Country | United States |
Headquarters | gaithersburg, maryland |
Phone Number | 2406541450 |
Industry | manufacturing |
CEO | Vipin K. Garg |
Website | altimmune.com |